Dipropyltryptamine

Dipropyltryptamine

Clinical data
Routes of administration	Ingestion, inhalation, intravenous or intramuscular injection
ATC code	none
Legal status
Legal status	DE: NpSG (Industrial and scientific use only) UK: Class A
Identifiers
IUPAC name N-[2-(1H-indol-3-yl)]ethyl-N-propylpropan-1-amine
CAS Number	61-52-9 Y
PubChem CID	6091
ChemSpider	5866 Y
UNII	S7272VWU50
CompTox Dashboard (EPA)	DTXSID30209847
Chemical and physical data
Formula	C16H24N2
Molar mass	244.382 g·mol−1
3D model (JSmol)	Interactive image
Melting point	174.5 to 178 °C (346.1 to 352.4 °F)
SMILES CCCN(CCC)CCC1=CNC2=C1C=CC=C2
InChI InChI=1S/C16H24N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h5-8,13,17H,3-4,9-12H2,1-2H3 Y Key:BOOQTIHIKDDPRW-UHFFFAOYSA-N Y
(verify)

N,N-Dipropyltryptamine (DPT) is a psychedelic entheogen belonging to the tryptamine family. Use as a designer drug has been documented by law enforcement officials since as early as 1968.^[1] However, potential therapeutic use was not investigated until the 1970s.^[2] It is found either as a crystalline hydrochloride salt or as an oily or crystalline base. It has not been found to occur endogenously. It is a close structural homologue of dimethyltryptamine and diethyltryptamine.

Frequent physical effects are nausea, numbness of the tongue or throat, and pupil dilation.